Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Contact
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
Van Lanschot Kempen Logo
May 2017
argenx
Issuer's Adviser
USD 115 million
Initial Public Offering on NASDAQ

argenx

argenx is a clinical stage biopharmaceutical company creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases

  • Kempen & Co acted as adviser to the issuer in this transaction

Fully focused on your future

Private Banking
  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland
Professional Solutions
Investment Management
Investment Banking
© Van Lanschot Kempen NV 2024About usSecurity and fraud awarenessPrivacy & cookiesDisclaimer